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ABSTRACT 
Equi ne her pes vi rus (EHV) 1 is an im por tant pa tho gen of hor ses. Upon in fec ti on, the vi rus re pli ca tes in the
up per res pi ra to ry tract. Then it spre ads to in ter nal or gans via a cell-as so ci a ted vi re mia. Lo cal re pli ca ti on in in -
ter nal or gans may re sult in abor ti on and ner vous sy stem dis or ders. The cur rent ly de sig ned vac ci nes are not able 
to in du ce sig ni fi cant pro tec ti on against EHV1-in du ced vi re mia. Ho we ver, se ver al vac ci nes are able to in du ce a
sig ni fi cant le vel of pro tec ti on against eit her abor ti on or ner vous sy stem dis or ders. Which im mu ne res pon ses
cor re la te with this pro tec ti on is so far unk nown. Be si des vac ci na ti on, ma na ge ment will re main a cru ci al fac tor in 
the pre ven ti on of EHV1-in du ced cli ni cal signs. Ma na ge ment me a su res in clu de the vac ci na ti on of all hor ses on
the pre mi ses to re du ce in fec ti on pres su re; the se pa ra te hou sing of young hor ses, adult hor ses and preg nant ma res;
strict hy gie ne me a su res and strict con trol of con tact with hor ses from out si de the pre mi ses. If, des pi te vac ci na ti on and 
tho rough ma na ge ment, an out break of EHV1-in du ced dis e a se oc curs, tre at ment with an ti vi ral agents may be use ful.
SAMENVATTING 
Equi e ne her pes vi rus (EHV) 1 is een be lang rijk pa tho geen bij paar den. Na in fec tie ver meer dert het vi rus eerst in het
adem ha lings stel sel. Ver vol gens ver spreidt EHV1 via een cel ge as so cieer de vi re mie naar in wen di ge or ga nen. Daar kan
een lo ka le vi rus ver meer de ring re sul te ren in abor tus of ze nuw stoor nis sen. De hui di ge be schik ba re vac cins kun nen het
op tre den van vi re mie na een in fec tie met wild-type vi rus niet voor ko men. Som mi ge vac cins kun nen wel een be scher -
ming in du ce ren te gen het op tre den van abor tus of ze nuw stoor nis sen. Wel ke im mu no lo gi sche res pons aan de ba sis ligt
van deze be scher ming is nog niet ge kend. Naast de vac ci na tie is ook het ma na ge ment zeer be lang rijk bij de pre ven tie van
EHV1-ge ïnduceerde symp to men. De ma na ge ment maat re ge len om vat ten het vac ci ne ren van alle paar den op het be drijf 
om de in fec tie druk te ver la gen, de ge schei den huis ves ting van jonge paar den, vol was sen paar den en dracht i ge mer ries,
een strik te hy gi ëne en het toe zicht op het con tact met paar den van bui ten het be drijf. Indien zich, on danks vac ci na tie en
uit ge brei de ma na ge ment maat re ge len, toch een uit braak van EHV1-ge ïnduceerde symp to men voord oet, dan kan even -
tu eel een be han de ling met an ti vi ra le ge nees mid de len over wo gen wor den. 
INTRO DUC TI ON
Equi ne her pes vi rus 1 (EHV1), a mem ber of the Alpha-
 herpesvirinae, is an im por tant pa tho gen of hor ses. Infec -
ti on with EHV1 oc curs via con tact with in fec ti ous se cre -
ti ons or via in ha la ti on of in fec ti ous ae ro sols. The pri ma ry 
site of re pli ca ti on is lo ca ted in the epi the lia of the up per
res pi ra to ry tract (Kydd et al., 1994a). Sub se quent ly, the
vi rus in va des through the epi the li al bar rier into dee per
tis su es of the res pi ra to ry tract (Pa tel et al., 1982; Kydd et
al., 1994a and b). Pri ma ry re pli ca ti on is ac com pa nied by
mild, trans ient res pi ra to ry dis e a se, which is self-li mi ting
wit hin 9 days fol lo wing in fec ti on (Gib son et al., 1992).
Four to 6 days af ter res pi ra to ry in fec ti on, EHV1-in fec ted 
mo no nu clear cells en ter the blood, re sul ting in a cell-as -
so ci a ted vi re mia. Vi re mia ge ne ral ly lasts un til 9 to 14 days
post-in fec ti on (Thein and Brown, 1988; Gib son et al.,
1992), alt hough McCar tan et al. (1995) re por ted vi re mia
las ting for 27 days. Car ried by in fec ted mo no nu clear
cells, EHV1 spre ads throug hout the body (Allen and
Bry ans, 1986). 
When EHV1-in fec ted mo no nu clear cells re ach the
preg nant ute rus, this may re sult in abor ti on, which ty pi -
cal ly oc curs in the last tri mes ter of preg nan cy. A key fac -
tor in the pa tho ge ne sis of EHV1-in du ced abor ti on is the
in fec ti on of en dot he li al cells in the en do me tri um by trans fer 
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of EHV1 from in fec ted mo no nu clear cells. The in fec ti on
of the en dot he li al cells re sults in vas cu lar da ma ge and sub -
se quent dis se mi na ti on of the vi rus into the fe tus (Jack son
et al., 1977; Eding ton et al., 1991; Smith et al., 1992,
1993; Smith and Bor chers, 2001).When a fe tus be co mes
in fec ted late in ge sta ti on, a li ving foal may be de li ve red.
Ho we ver, such fo als are usu al ly weak and de pres sed, and 
they die wit hin 24 hours post par tum. Some fo als ap pe ar
nor mal at birth, but de ve lop se ve re res pi ra to ry dis tress
wit hin 18 to 24 hours and suc umb wit hin 3 days.
When EHV1-in fec ted mo no nu clear cells re ach the
ner vous sy stem, neu ro lo gi cal dis or ders may be in du ced.
Eding ton et al. (1986) pro vi ded clear evi den ce that EHV1
can in fect en dot he li al cells of the ner vous sy stem and that 
this forms the ini t al step in the in duc ti on of vas cu lar le si ons. 
The vas cu lar le si ons re sult in se con da ry hy poxic de ge ne -
ra ti on of ad ja cent neu ral tis sue and, sub se quent ly, in se -
ve re ner vous sy stem dis or ders such as ataxia, pa ra ly sis,
blad der pa ra ly sis and uri ne in con ti nen ce, as well as cra ni al
ner ve de fi cits and/or signs of ce re bral in vol ve ment.
In or der to pro tect hor ses against EHV1 in fec ti on, they
can be vac ci na ted. The pur po se of vac ci na ti on is two fold.
First, vac ci na ti on is me ant to mi ni mi ze vi rus re pli ca ti on in
the res pi ra to ry tract upon sub se quent ex po su re to vi ru lent
EHV1. In this man ner, na sal shed ing of vi rus will be re du -
ced, as will the oc cur en ce of res pi ra to ry dis or ders. Se cond,
vac ci na ti on should pre vent the oc cur en ce of abor ti on
and/or ner vous sy stem dis or ders eit her by pre ven ting
vi re mia or by pre ven ting trans mis si on and/or sub se quent 
re pli ca ti on of EHV1 in in ter nal or gans. The first pur po se
of vac ci na ti on seems to be ful fil led by the avai la ble vac -
ci nes, as de mon stra ted by re du ced na sal vi rus ti ters and
the re du ced se ve ri ty of res pi ra to ry dis e a se upon chal -
lenge in fec ti on of vac ci na ted hor ses (Bur rows et al.,
1984, Hel dens et al., 2001, Good man et al., 2006). Ho w -
e ver, the ef fi ca cy of the cur rent com mer ci al and ex pe ri -
men tal vac ci nes to pro tect hor ses against EHV1-in du ced
vi re mia and sub se quent abor ti on or neu ro lo gi cal dis or -
ders is highly va ri a ble and none of them can gu a ran tee
100% pro tec ti on. 
The pur po se of this ar ti cle is to re view the stu dies that
ad dress the po ten ti als and li mi ta ti ons of the cur rent com -
mer ci al and ex pe ri men tal vac ci nes in the pre ven ti on of
vi re mia, abor ti on and ner vous sy stem dis or ders in hor -
ses. Be si de the se stu dies, many ot her stu dies have des cri -
bed new ap pro aches for vac ci na ti on against EHV1-in du -
ced dis e a se. They in clu de stu dies on in ac ti va ted vac ci nes 
com pri sing one or more ma jor vi ral gly copro teins such
as gB (Ku kre ja et al., 1998), gC (Te wa ri et al., 1995) or
gD (Wee ra sing he et al., 2006), on de l  ti on mu tants lac -
king ge nes en co ding for one or more ma jor vi ral gly -
copro teins such as gB or gM (Neu bau er et al., 1997), gC
(Oster rie der, 1999), gD (Csellner et al., 2000), gE or gI
(Tsu ji mu ra et al., 2006), and on DNA vac ci nes ba sed on
the co ding re gi on for gD (Rui ten berg et al., 1999) or gp2
(Le arm onth et al.., 2003). Ho we ver, none of the lat ter
stu dies des cri bed the pro tec ti ve pro per ties of the vac ci -
nes against EHV1-in du ced dis e a se in hor ses. The re fo re,
they re mai ned out si de the sco pe of this ar ti cle. 
PO TEN TI ALS AND LI MI TA T I ONS OF VAC CI NES
TO PRE VENT VI RE MIA
If a vac ci ne were de ve lo ped that could li mit or block
the trans port of vi rus to in ter nal or gans via the cel-as so -
ci a ted vi re mia, then the oc cur en ce of abor ti on and ner -
vous sy stem dis or ders could be re du ced. Many stu dies
have ad dres sed the po ten ti al of vac ci nes to pro tect hor ses
against cell-as so ci a ted vi re mia. The se in clu de stu dies on
com mer ci al ly avai la ble and ex pe ri men tal ly de sig ned vac -
ci nes. An over view of the pro tec ti ve ef fi ca cy of the se two
ty pes of vac ci nes against vi re mia is pre sen ted in Ta bles 1
and 2, res pec ti ve ly.
Com mer ci al vac ci nes
The first stu dy ad dres sing the ef fect of an in ac ti va ted
vac ci ne on EHV1-in du ced vi re mia was per for med by
Bur rows et al. in 1984. They exa mi ned the ef fec ti ve ness
of Pneu ma bort-K Ò , a who le vi rus in ac ti va ted and oil-
 adju van ted vac ci ne con tai ning EHV1. The in ci den ce of
EHV1- indu ced vi re mia was si mi lar for vac ci na ted ma res
and non-vac ci na ted con trol ma res (Ta ble 1), as was the
du ra ti on of vi re mia (8 to 14 days for vac ci na tes and con -
trols). Si mi lar re sults were ob tai ned for ye ar lings and
two-year-old po nies vac ci na ted with Pneu ma bort-K Ò .
Vi re mia was ap a rent in all ani mals upon chal enge and
la sted for 4 to 10 days (Bur rows et al., 1984). Bür ki et al.
(1990) were also una ble to de mon stra te a sig ni fi cant re -
duc ti on in the num ber of vi re mic ani mals upon vac i na ti on
with Pneu ma bort-K Ò  (Ta ble 1). 
In 2001, Hel dens et al. per for med a vac ci na ti on/chal -
lenge stu dy with Du vaxyn EHV1,4Ò , a who le vi rus in ac ti va -
ted and car bo mer-ad ju van ted vac ci ne con tai ning EHV1
and EHV4. Preg nant ma res that had pre vi ous ly been in
con tact with EHV were vac i na ted three ti mes and chal -
leng ed 4 weks la ter. A non-vac i na ted group was in clu -
ded as a con trol. All ma res, ir es pec ti ve of their vac ci na ti -
on sta tus, be ca me vi re mic upon chal enge. Mo re o ver, the 
du ra ti on of vi re mia was hard ly af fec ted by vac ci na ti on.
Addi ti o nal ly, Hel dens et al. (2001) exa mi ned the oc cur -
ren ce of vi re mia in vac ci na ted and chal leng ed fo als that
had not ben pre vi ous ly in con tact with EHV. Only 30%
of vac ci na ted fo als be ca me vi re mic upon chal lenge, com -
pared to 80% of con trol fo als. This sig ni fi cant ef fect of
Du vaxyn EHV1,4Ò  on the pre ven ti on of vi re mia in a group 
of EHV-nai ve fo als seems so mew hat sur pri sing. Indeed,
the same vac ci ne was una ble to pre vent vi re mia in a
group of ma res that all had been in con tact with EHV ear -
lier in life. The vi ru len ce of the chal lenge vi rus may pos -
si bly have af fec ted the out co me of the chal lenge in fec ti -
on. The Ab4 strain used to chal lenge the ma res is known
to be highly vi ru lent (Crow hurst et al., 1981; Mum ford et
al., 1994). The 121412 strain used to chal lenge the fo als
is li ke ly to be of much lo wer vi ru len ce, sin ce even in the
non-vac i na ted group not all fo als be ca me vi re mic upon
chal lenge (Hel dens et al., 2001).
Very re cent ly, the in ac ti va ted vac ci ne Flu-Vac Inno -
va tor 6Ò  has been te sted for its ef i ca cy to pre vent vi re mia
(Good man et al., 2006), but also this vac i ne was una ble
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to re du ce eit her the num ber of vi re mic hor ses or the
amount or du ra ti on of vi re mia upon chal lenge (Table 1).
Be si des in ac ti va ted vac ci nes, live-at te nu a ted vac ci nes
are used for the pre ven ti on of EHV1-in du ced dis e a se. Pre -
vac ci nolÒ is a com mer ci al live-at te nu a ted Rac-H vi rus
vac ci ne de ve lo ped by at te nu a ting the RacL11 strain of
EHV1 via se ri al pas sa ges on he te ro lo gous cells (Woy -
ciechow ska, 1960; Woy ciechow ska et al., 1980). Bürki
et al. (1990) de mon stra ted vi re mia in the vast ma jo ri ty of
vac ci na ted hor ses upon sub se quent chal lenge in fec ti on
(Ta ble 1). Ho we ver, in 4 out of the 8 vi re mic ani mals, in -
fec ted mo no nu clear cells were only de tec ted in the blood
on one oc ca si on (at 4 days post-chal lenge). Sin ce the stu dy
lac ked a con trol group of non-vac ci na ted hor ses, it could
not be con clu ded whe ther this was an ef fect of vac ci na ti -
on. For the live-at te nu a ted vac ci ne Rhi no mu neÒ, no sig -
ni fi cant ef fect was ob ser ved be tween vac ci na tes and con -
trols, eit her on the mean num ber of vi re mic ani mals or on
the mean amount and du ra ti on of vi re mia upon sub se -
quent chal lenge in fec ti on (Good man et al., 2006).
Expe ri men tal vac ci nes
Many re search ers have de sig ned and te sted vac ci nes
that have not (yet) been com mer ci a li zed for hor ses. The se
in clu de in ac ti va ted vac ci nes ba sed on EHV1-spe ci fic
gly copro teins, live-at te nu a ted vac ci nes ba sed on EHV1
mu tants and DNA vac ci nes.
Mat su mu ra et al. (1996) exa mi ned a vac ci ne ba sed on
the live-at te nu a ted KyA strain ob tai ned by se ri al pas sa -
ges on he te ro lo gous cells (Ran dall and Law son, 1962;
Per due et al., 1974). All hor ses in clu ded in the vac ci na ti on/
chal lenge stu dy de ve lo ped vi re mia upon chal lenge, irres -
pec ti ve of their vac ci na ti on sta tus. Ho we ver, the maxi mum
du ra ti on of vi re mia was re du ced in the vac ci na ted hor ses
(3 to 6 days) when com pa red to the con trol hor ses (16 to
19 days). 
The live-at te nu a ted C147 strain was ob tai ned by gro -
wing a Ger man abor ti on iso la te of EHV1 in the pre sen ce
of 5-bro mo-2-de oxy uri di ne.  By sub se quent clo ning,
clo ne 147 was ob tai ned, which was found to be re stric ted
for growth at tem pe ra tu res abo ve nor mal body tem pe ra -
tu re (Pa tel et al., 2003a). The re sults of the vac ci na ti on/
chal lenge stu dy were very pro mi sing. A sing le in tra na sal
vac ci na ti on was able to in du ce com ple te pro tec ti on against
vi re mia in one- and two-year-old hor ses upon chal lenge
at 6 weeks post-im mu ni za ti on (Pa tel et al., 2003b). Also
at la ter time points af ter vac ci na ti on, sig ni fi cant pro tec ti on
against vi re mia was ob ser ved (Ta ble 2). When adult ma res 
were chal leng ed at 4 or 5-6 months post im mu ni za ti on,
50% and 60% of the ma res, res pec ti ve ly, did not de ve lop
de tec ta ble vi re mia (Pa tel et al., 2003a). Des pi te this sig -
ni fi cant pro tec ti ve ef fect, prac ti cal use of the vac ci ne has
been hin de red. This is most li ke ly due to the fact that the
vac ci ne it self can in du ce vi re mia in 30-70% of hor ses
(Pa tel et al. 2003 a and b), the re by enab ling the mu tant vi -
rus to re ach the in ter nal or gans and, in the worst case, to
cau se abor ti on. 
Sla ter et al. (1993) and Te wa ri et al. (1993) con struc ted
a mu tant that spe ci fi cal ly lac ked the thy mi di ne kinase. As
for the C147 mu tant, im mu ni sa ti on with the TK- mu tant
also exer ted an ef fect on vi re mia upon chal lenge. The
mu tant could not pre vent vi re mia, but it was able to in du -
ce a 10-fold re duc ti on in the num ber of in fec ted mo no -
nuclear cells in the blood (1/106) when com pa red to non-
 im mu ni zed con trols (1/105) (Sla ter et al., 1993). A live- at -
te nu a ted vac ci ne ba sed on a gE-/gI- mu tant was una ble to
re du ce eit her the num ber of vi re mic ani mals or the du ra ti -
on of vi re mia (Mat su mu ra et al., 1998). The ex ten si ve -
ness of vi re mia was not ad dres sed in this stu dy.
Be si des vac ci nes ba sed on mu tants lac king ex pres si on 
of one or more ma jor pro teins, se ver al vac ci nes have
been de sig ned in ste ad to ex press only one or more ma jor
pro teins, but to lack ex pres si on of all ot her pro teins. Cook 
and col le a gu es (1990) de sig ned such an in ac ti va ted vac ci ne 
con tai ning all the ma jor EHV1 gly copro teins pre sen ted
by im mu ne sti mu la ting com plexes or ISCOMs. Han nant
et al. (1993) de mon stra ted that all fo als vac ci na ted with
the ISCOM vac ci ne de ve lo ped vi re mia upon chal lenge
in fec ti on, but that the du ra ti on and amount of the vi re mia
were sig ni fi cant ly re du ced com pa red to non-vac ci na ted 
fo als. 
Most ot her stu dies are less ex ten si ve and, un for tu na te ly,
only ad dress the num ber of vi re mic ani mals among vac -
ci na tes and con trol, but lack data on amount and du ra ti on
of vi re mia. Ne ver the less, it is stri king that none of the se
vac ci nes are able to sig ni fi cant ly af fect the num ber of
hor ses with vi re mia (Ta ble 2). 
Anot her at trac ti ve ap pro ach to im mu ni zing with one
or more EHV1 pro teins is via DNA vac ci na ti on. This in -
du ces both po tent CTL and an ti bo dy res pon ses, and the
sa fe ty con cerns are mi ni mal (Has sett and Whit ton, 1996).
Ho we ver, Minke et al. (2006) de mon stra ted that DNA
vac ci na ti on with a DNA vac ci ne con tai ning plas mids for
gB, gC and gD did not have a po si ti ve im pact on the pre -
ven ti on of vi re mia (Ta ble 2). A par ti cle-me di a ted DNA
vac ci na ti on ba sed eit her on gB/gC/gD or on IE/UL5 was
des cri bed by So boll et al. (2006). Vac ci na ti on and sub se -
quent chal lenge of 1-year-old po nies re sul ted in vi re mia
in 4 out of 5 ani mals for both vac ci nes. Sur pri sing ly, chal -
lenge in fec ti on of non-vac ci na ted con trol ani mals re sul -
ted in vi re mia in only 1 out of 5 ani mals, strong ly sug ge -
sting that vac ci na ti on did not have any im pact on the
oc cur ren ce of vi re mia. 
From the abo ve-men ti o ned re sults, we can con clu de
that the cur rent ly avai la ble vac ci nes have only li mi ted or
no po ten ti al to pro tect hor ses against vi re mia upon sub se -
quent chal lenge in fec ti on. Ho we ver, se ver al stu dies re -
port a re duc ti on in the num ber of hor ses with abor ti on or
ner vous sy stem dis or ders af ter vac ci na ti on, as dis cus sed
below.  
PO TEN TI ALS AND LI MI TA TI ONS OF VAC CI NES
TO PRE VENT ABOR TI ON
Stu dies that ad dress the pro tec ti ve po ten ti al of vac ci nes
against abor ti on are sum ma ri zed in Ta bles 1 and 2.
Vlaams Dier ge nees kun dig Tijd schrift, 2007, 76 189
190 Vlaams Dier ge nees kun dig Tijd schrift, 2007, 76
.se sroh ni sre dr osid 
met sys suo vren dna n oi troba ,ai
 me riv de cu dni-1
V
HE no se ni ccav la tne












 me riv fo .on
se sroh







sn oi troba fo .on





































































































































































































































































































































 mre ted ton :d




w ;e ni ccav evil-dei fi do
m :VL
M ;e ni ccav de ta vi tc ani :.tcanI ;sre dr osid 
met sys suo vren :
DS
N N
.eerf ne goh tap ci fi ceps :FPS ;gnol eu qinu :L
U ;y lrae e t ai de
 m
mi :EI ;e sa nik e ni di
 myht :
KT ;e vi ti snes e ru ta re p
met :ST ;sexel p
moc gni ta lu




OCSI ;nie torpo cylg :g ;de vre sbo enon :sbo
Com mer ci al vac ci nes
Hel dens et al. (2001) exa mi ned the pro tec ti ve ef fect of 
Du vaxyn EHV1,4Ò against EHV1-in du ced abor ti on. As
des cri bed abo ve, preg nant ma res were vac ci na ted three
ti mes and chal leng ed 4 weeks la ter. It was found that the
in ci den ce of EHV1-in du ced abor ti on was clear ly re du -
ced in the vac ci na ted (1/5 abor ted) com pa red to the non-
 vac ci na ted ma res (4/4 abor ted). This is an in te res ting fin -
ding, kno wing that all ma res, ir res pec ti ve of their vac ci -
na ti on sta tus, did be co me vi re mic upon chal lenge. It
could sug gest that vac ci na ti on with Du vaxyn EHV1,4Ò re -
du ces the num ber of in fec ted mo no nu clear cells per mare
and, sub se quent ly, re du ces the chan ce of in ter ac ti on of
the se in fec ted mo no nu clear cells with en dot he li al cells of
the preg nant ute rus. Alter na ti ve ly, the vac ci ne may in du ce
cert ain pro tec ti ve res pon ses that aid in li mi ting the trans -
mis si on of EHV1 from the car rier leu ko cy te to en dot he lial
cells of the ute rus or that aid in li mi ting the ex ten si ve ness
of le si ons in the en dot he li um of the preg nant ute rus.
In con trast to Du vaxyn EHV1,4Ò, the in ac ti va ted Pneu -
ma bort-KÒ vac ci ne was una ble to in du ce pro tec ti on
against abor ti on in a vac ci na ti on/chal lenge stu dy (Bur -
rows et al., 1984) (Ta ble 1). Abor ti on was also evi dent in
50% of Pneu ma bort-KÒ-vac ci na ted ma res in the vac ci -
na ti on/chal lenge ex pe ri ment per for med by Bürki et al.
(1990). Ho we ver, the lat ter re search ers did not in clu de a
non-vac ci na ted con trol group and, the re fo re, it is not pos -
si ble to jud ge the ef fect of the vac ci ne ba sed on their re -
sults. Des pi te the ne ga ti ve fin dings in the ex pe ri men tal
vac ci na ti on/chal lenge stu dies, Bry ans and Allen (1982)
de mon stra ted a po si ti ve ef fect of vac ci na ti on in the field.
They found that, upon in tro duc ti on of vac ci na ti on with
Pneu ma bort-KÒ in Ken tuc ky, the in ci den ce of EHV1-in du -
ced abor ti on de cli ned from 6.8/1000 in 1977 to 1.8/1000 in
1980. 
Also for Pre vac ci nolÒ the re are some con tra dic to ry
fin dings con cer ning its pro tec ti ve ef fect against EHV1-
 in du ced abor ti on. Von Ben ten and Pet zoldt (1977) per -
for med a six-year field sur vey in Ger man tho roughbreds
and re por ted that EHV1 abor ti ons oc cur red as fre quent ly
in vac ci na ted as in non-vac ci na ted ma res. On the ot her
hand, in tro duc ti on of the vac ci ne on 6 farms in Po land re -
sul ted in a slight, but sig ni fi cant de cre a se in the num ber
of fe tal and ne o na tal foal los ses from 11.8% to 8.9% (Fry -
mus et al., 1986). In a field tri al per for med over a pe ri od
of 6 ye ars by Bec ker (1988), no ca ses of vi rus abor ti on
were de tec ted when ma res were vac ci na ted ac cor ding to
the manufacturer’s in struc ti ons. Bürki et al. (1990) car -
ried out an ex pe ri men tal vac ci na ti on/chal lenge stu dy
with Pre vac ci nolÒ. Two out of 4 vac ci na ted preg nant ma -
res abor ted upon chal lenge. It could not be con clu ded
whe ther vac ci na ti on had re du ced the abor ti on rate, sin ce
the stu dy lac ked a con trol group of non- vac ci na ted preg nant 
ma res.
Expe ri men tal vac ci nes
Among the many stu dies on the pro tec ti ve ef fect of
ex pe ri men tal vac ci nes, only one ad dres ses the pro tec ti ve
po ten ti al against abor ti on (Pa tel et al., 2003a). Preg nant
ma res re cei ved a sing le in tra na sal vac ci na ti on with the
live-at te nu a ted C147 mu tant. Fol lo wing this vac ci na ti on
pro to col, only 17% and 20% of ma res abor ted upon sub -
se quent chal lenge at 4 and 5-6 months, res pec ti ve ly. In
the con trol group, in con trast, all ma res abor ted. Des pi te
the se pro mi sing re sults, prac ti cal use of the vac ci ne has
been hin de red, most li ke ly due to sa fe ty re a sons, as dis -
cus sed above.
PO TEN TI ALS AND LI MI TA TI ONS OF VAC CI NES
TO PRE VENT NER VOUS SY STEM DIS OR DERS
Up till now, only one stu dy has ad dres sed the pro tec ti ve
po ten ti al of vac ci nes against ner vous sy stem dis or ders
(Good man et al., 2006). The main re a son for this li mi ted
num ber of stu dies is that the re are still very few good  ex -
pe ri men tal mo dels to in du ce ner vous sy stem dis or ders in
hor ses. Good man et al. (2006) im mu ni zed hor ses with
the in ac ti va ted vac ci ne Flu-vac Inno va tor 6Ò or the mo di -
fied-live vac ci ne Rhi no mu neÒ. Non-vac ci na ted hor ses
were in clu ded as a con trol. Upon chal lenge, ner vous sy s -
tem dis or ders were ob ser ved in the con trol hor ses (3/5)
and in the hor ses vac ci na ted with the in ac ti va ted vac ci ne
(3/5). Among the hor ses vac ci na ted with the mo di fied-
 live vac ci ne, none de ve lo ped ner vous sy stem dis or ders.
Again, this is an in te res ting fin ding, sin ce all hor ses, ir res -
pec ti ve of their vac ci na ti on sta tus, be ca me vi re mic upon
chal lenge. Mo re o ver, the amount and du ra ti on of vi re mia 
were si mi lar (Good man et al., 2006). As men ti o ned abo ve,
this may in di ca te that the mo di fied-live vac ci ne in du ced
a cert ain pro tec ti ve res pon se that li mi ted the trans mis si on 
of EHV1 from the car rier leu ko cy te to en dot he li al cells of 
the ner vous sy stem or that li mi ted the ex ten si ve ness of le -
si ons in the en dot he li um of the ner vous sy stem. The un -
ra ve ling of the un der ly ing pro tec ti ve im mu ne mecha -
nism(s) that oc cur(s) at the le vel of the en dot he li um may
be an im por tant step in fu tu re vac ci ne de ve lop ment.
CON CLU DING REM ARKS
In re vie wing the va ri ous vac ci na ti on/chal lenge stu -
dies, it has be co me clear that the cur rent ly de sig ned vac -
ci nes are not able to in du ce sig ni fi cant pro tec ti on against
EHV1-in du ced vi re mia. Ho we ver, se ver al vac ci nes are
able to in du ce sig ni fi cant pro tec ti on against eit her abor ti on
or ner vous sy stem dis or ders. Which im mu ne res pon ses
cor re la te with this pro tec ti on is so far unk nown. They
may in clu de res pon ses that li mit the trans mis si on of
EHV1 from the car rier leu ko cy te to en dot he li al cells of
the tar get or gans. Res pon ses that li mit the ex ten si ve ness
of le si ons in the en dot he li um of the tar get or gan and, con -
se quent ly, li mit the de vast ating ef fects of throm bo sis,
vas cu li tis and anoxe mia may also be in vol ved. The un ra ve -
ling of the un der ly ing pro tec ti ve im mu ne me cha nism(s)
that oc cur(s) at the le vel of the en dot he li um may be an
im por tant step in fu tu re vac ci ne de ve lop ment.
EHV re search ers may also find help ful clu es by look -
ing more clo se ly into the im mu ne res pon ses rai sed at the
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le vel of the res pi ra to ry tract upon na tu ral in fec ti on with
EHV1. In any case, the se res pon ses were found to be ful ly
pro tec ti ve against vi ral re pli ca ti on in the res pi ra to ry tract
for up to 2 months (Gib son et al., 1992; Sla ter et al., 1993; 
Te wa ri et al., 1993), and ful ly pro tec ti ve against vi re mia
for up to 6 months post-in fec ti on (Eding ton et al., 1990;
van der Meu len, un pu blis hed re sults). If vi re mia is pre -
ven ted, then sub se quent spre ad to the preg nant ute rus
and the ner vous sy stem are pre ven ted as well. Once the
mecha nisms of pro tec ti on have been un ra ve led, a vac ci ne
may be de sig ned that in du ces si mi lar res pon ses. Kee ping 
the pro tec ti ve po ten ti als of the C147 mu tant in mind (Pa -
tel et al., 2003a), such vac ci ne is li ke ly to be a lo cal ly ad -
mi nis te red, live-at te nu a ted vac ci ne.
Be si des vac ci na ti on, ma na ge ment will re main a cru ci al
fac tor in the pre ven ti on of EHV1-in du ced cli ni cal signs.
Vac ci na ti on ac cor ding to the manufacturer’s in struc ti ons 
should be per for med for all hor ses on the pre mi ses so that
in fec ti on pres su re on the pre mi ses is re du ced. Sound ma -
na ge ment also in clu des the se pa ra te hou sing of young
hor ses, adult hor ses and preg nant ma res, strict hy gie ne
me a su res, and strict con trol of con tact with hor ses from
out si de the pre mi se. The com bi na ti on of ac cu ra te vac ci -
na ti on with sound ma na ge ment pro ved ef fec ti ve in sig ni -
fi cant ly re du cing the chan ce of EHV1-in du ced abor ti on
in Ken tuc ky, USA (Ti mo ney, per so nal com mu ni ca ti on).
If, des pi te vac ci na ti on and tho rough ma na ge ment, an
out break of EHV1-in du ced dis e a se ne ver the less oc curs,
re cent stu dies have de mon stra ted the use ful ness of an ti -
vi ral the ra py (Wil kins et al., 2005; Bentz et al., 2006;
Garré et al., 2006, 2007).
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Uit het ver le den  
